Trials / Not Yet Recruiting
Not Yet RecruitingNCT07160790
Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease
Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux(NERD) Disease: Double-blind, Randomized
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 321 (estimated)
- Sponsor
- Onconic Therapeutics Inc. · Industry
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the efficacy and safety of JP-1366 in Patients with NERD
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JP-1366 + placebo | taking JP-1366 + placebo |
| DRUG | Placebo + Placebo | taking placebo + placebo |
Timeline
- Start date
- 2025-09-02
- Primary completion
- 2026-06-30
- Completion
- 2026-06-30
- First posted
- 2025-09-08
- Last updated
- 2025-09-08
Source: ClinicalTrials.gov record NCT07160790. Inclusion in this directory is not an endorsement.